Dr. Xiaosuo Wang | Point-of-Care | Best Researcher Award
Dr. Xiaosuo Wang | Point-of-Care | The University of Sydney | Australia
Assoc. Prof. Dr. Dr. Xiaosuo Wang is an accomplished academic and biomedical researcher at The University of Sydney, Australia, renowned for his contributions to cardiac metabolism, molecular sensing, and translational biomedical engineering. With a solid academic foundation culminating in a Ph.D. in Biomedical Engineering from a leading Australian university, Dr. Wang has dedicated his career to exploring the complex interplay between metabolic remodeling, molecular expression, and cardiac function. His professional experience encompasses teaching, mentoring, and conducting multidisciplinary research across biomedical signal analysis, metabolic sensing, and age-associated cardiovascular studies, combining advanced imaging, computational modeling, and molecular profiling techniques. Over the years, Dr. Wang has developed a deep research interest in the mechanisms of heart failure, mitochondrial bioenergetics, metabolic regulation, and the role of novel biomarkers in cardiac health, contributing to advancements in personalized medicine and therapeutic strategies. His research skills are reflected in his expertise in multi-omics integration, biosensor development, data-driven analysis, and experimental validation, supporting high-quality publications in internationally recognized journals such as European Journal of Heart Failure, Circulation Research, and Aging Cell. Dr. Wang has authored 38 peer-reviewed papers with 772 citations and an h-index of 17, underscoring the global recognition and scholarly impact of his work. He has collaborated with over 200 international co-authors, demonstrating his commitment to fostering scientific cooperation and innovation. His achievements have been recognized through multiple academic honors, invited lectureships, and leadership roles in research consortia advancing metabolic sensing technologies. Beyond research, he actively engages in mentoring doctoral students and postdoctoral scholars, contributing to the development of the next generation of biomedical engineers and clinicians. Dr. Wang’s professional affiliations include memberships in IEEE, the American Heart Association, and the Australasian Society for Biomaterials, reflecting his dedication to interdisciplinary advancement and scientific service. His continuous pursuit of excellence has positioned him as a thought leader in the intersection of engineering and medicine, promoting innovation in sensing-based diagnostics and metabolic therapies.
Selected Publications
-
Wang, X., et al. (2025). Mechanical unloading is accompanied by reverse metabolic remodelling in the failing heart: Identification of a novel citraconate-mediated pathway. European Journal of Heart Failure,
-
Wang, X., et al. (2025). The Heart Has Intrinsic Ketogenic Capacity that Mediates NAD+ Therapy in HFpEF. Circulation Research, 2 citations.
-
Wang, X., et al. (2025). The Human Cardiac “Age-OME”: Age-Specific Changes in Myocardial Molecular Expression. Aging Cell,
-
Wang, X., et al. (2024). Metabolic Reprogramming in the Heart: Integrating Molecular Sensing and Therapeutic Insights. Frontiers in Cardiovascular Medicine, 15 citations.
-
Wang, X., et al. (2023). Bioenergetic Sensing and Molecular Adaptation in Cardiac Aging and Failure. Journal of Molecular and Cellular Cardiology, 20 citations.